Publications — Radcliffe Department of Medicine

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities.

Sacco S. et al, (2024), Diabetologia

Exploring sexual function in adrenal insufficiency: findings from the Dual RElease hydrocortisone versus conventionAl glucocorticoid replaceMent therapy in hypocortisolism (DREAM) trial.

Hasenmajer V. et al, (2024), Andrology

Development of diagnostic algorithm for Cushing's syndrome: a tertiary centre experience.

Efthymiadis A. et al, (2024), J Endocrinol Invest

Predicting postoperative hypocortisolism in patients with non-aldosterone-producing adrenocortical adenoma: a retrospective single-centre study.

Bonaventura I. et al, (2024), J Endocrinol Invest

Copeptin and the syndrome of inappropriate antidiuresis (SIAD) after pituitary transsphenoidal surgery

Efthymiadis A. et al, (2024), Endocrinology, Diabetes and Metabolism, 7

C-Cell Hyperplasia and Cystic Papillary Thyroid Carcinoma in a Patient with Type 1B Pseudohypoparathyroidism and Hypercalcitoninaemia: Case Report and Review of the Literature.

Ferrari D. et al, (2023), J Clin Med, 12

Effects of Dual-Release Hydrocortisone on Bone Metabolism in Primary and Secondary Adrenal Insufficiency: A 6-Year Study.

Hasenmajer V. et al, (2023), J Endocr Soc, 8

Pituitary adenoma consistency affects postoperative hormone function: a retrospective study

De Alcubierre D. et al, (2023), BMC Endocrine Disorders, 23

Treating the Side Effects of Exogenous Glucocorticoids; Can We Separate the Good From the Bad?

Pofi R. et al, (2023), Endocr Rev, 44, 975 - 1011

Multivariable Model to Predict an ACTH Stimulation Test to Diagnose Adrenal Insufficiency Using Previous Test Results.

Lawrence NR. et al, (2023), J Endocr Soc, 7

Tall stature and gigantism in transition age: clinical and genetic aspects-a literature review and recommendations.

Sada V. et al, (2023), J Endocrinol Invest

EMAS position statement: Testosterone replacement therapy in older men.

Kanakis GA. et al, (2023), Maturitas, 178

Long-term health consequences of congenital adrenal hyperplasia.

Pofi R. et al, (2023), Clin Endocrinol (Oxf)

Assessing treatment adherence is crucial to determine adequacy of mineralocorticoid therapy.

Pofi R. et al, (2023), Endocr Connect, 12

"A morning cortisol is the most effective clinical predictor of short synacthen test outcome": A tertiary care centre experience.

Mathara Diddhenipothage SAD. et al, (2023), Clin Endocrinol (Oxf)

Altered thyroid feedback loop in Klinefelter syndrome: a cohort study from infancy through the transition into adulthood.

Carlomagno F. et al, (2023), J Clin Endocrinol Metab

Glucocorticoids and cognitive function: a walkthrough in endogenous and exogenous alterations.

De Alcubierre D. et al, (2023), J Endocrinol Invest

Testicular dysfunction in 47, XXY boys: when it all begins. A semi-longitudinal study.

Pozza C. et al, (2023), J Clin Endocrinol Metab

11β-HSD1 inhibition in men mitigates prednisolone-induced adverse effects in a proof-of-concept randomised double-blind placebo-controlled trial.

Othonos N. et al, (2023), Nat Commun, 14

Susceptibility and characteristics of infections in patients with glucocorticoid excess or insufficiency: the ICARO tool.

Minnetti M. et al, (2022), Eur J Endocrinol, 187, 719 - 731

Load More

Include forthcoming?